Product

Alprostadil

Name

PROSTIN

INN Name

Alprostadil

FDA Approved

Yes

3 clinical trials

2 organizations

3 indications

3 documents

Indication

Congestive Heart Failure

Indication

Indication

Congenital Heart Disease

Clinical trial

Phase 3 Study of Alprostadil Continuous Intravenous Infusion to Maintain Clinical Stability in Severe Heart Failure Patients

Status: Not yet recruiting, Estimated PCD: 2024-11-01

Clinical trial

Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

Status: Not yet recruiting, Estimated PCD: 2024-12-31

Clinical trial

The Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow After the Bidirectional Cavopulmonary Connection

Status: Terminated, Estimated PCD: 2021-02-24

Document

DailyMed Label: PROSTIN

Organization

Pharmacia & Upjohn Company LLC

Document

DailyMed Label: Edex

Organization

Document

DailyMed Label: Caverject Impulse